Published: February 09, 2010
Baldness Is Inherited From The Father As Well As The Mother: HairDX Improves Genetic Baldness Test By Looking At Both Sides
IRVINE, Calif. - (BUSINESS WIRE) - HairDX, developer of the first genetic
test for predicting the risk of male and female pattern hair loss
(Androgenetic Alopecia) today announced it is now able to provide
doctors with an improved prediction by looking at genetic variants
inherited from the mother combined with the risk for baldness attributed
by the father.
"It is well known in the medical community that pattern hair loss is
inherited in a complex fashion with paternal as well as maternal
influence. While the maternal inheritance of certain gene variants are
necessary for the development of pattern hair loss, they are not
sufficient. The HairDX test has improved predictive power by
incorporating both maternal as well as paternal influences," says Sharon
Keene, M.D. Chief Medical Officer of HairDX.
"A man whose father has even a minimal amount of hair loss who tests
positive for the variant AR gene has over 80% chance of developing male
pattern hair loss," says Andy Goren, President and CEO of HairDX.
The news is better for men whose fathers did not experience balding. A
man whose father has no signs of hair loss who tests negative for the
variant AR gene has over 90% chance of not developing male pattern hair
loss.
"With the improved predictive value of the HairDX genetic test, a doctor
is better informed than ever before, and can provide a personalised
analysis of an individual's likelihood of developing Androgenetic
Alopecia, the most common type of hair loss," said Goren.
The HairDX genetic test for baldness is available through doctors only.
About HairDX, LLC.
HairDX (www.hairdx.com
and Twitter:
@HairDX) is a molecular dermatology company founded in 2007 by
leading researchers and specialists in genetics and dermatology. It is
dedicated to the research and development of new prescription based
therapies for skin conditions tailored to an individual's genetic makeup.
The company introduced HairDX, a genetic screening test for Female and
Male Pattern Baldness (Androgenetic Alopecia). The HairDX test
collection kit is listed with Japan's Pharmaceuticals
and Medical Devices Agency (PMDA) and the United States Food and Drug
Administration (FDA) as a Class I medical device.
The
HairDX Genetic Test for Hair Loss is also available as a CE Marked
product under the European In Vitro Diagnostic Directive.
HairDX, LLC.
Jon Boroshok, 978-502-1055
Public Relations
jonb@hairdx.com
Twitter:
@HairDX
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News